Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study
Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study
K. K. Gandhi, Viswanathan Mohan, Rakesh Sahay, Vaibhav Salvi et al.
Journal
Diabetes Therapy
Topics
Diabetes Management and Research
article
Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study
K. K. Gandhi, Viswanathan Mohan, Rakesh Sahay, Vaibhav Salvi, Shalini Menon, ARVIND GADEKAR, Sunil Jain, Kiran Pal Singh, Balamurugan Ramanathan, Bipin Sethi, Sreenivasa Murthy
article en
Abstract
No abstract available for this paper.
Publication Tag
Diabetes TherapyVol. 16(7)
Institutions
CARE Hospitals (IN), Kovai Medical Center and Hospital (IN), Dr. Mohan's Diabetes Specialities Centre (IN), Sanofi (India) (IN), Sri Kalabyraveshwara Swamy Ayurvedic Medical College, Hospital and Research Center (IN), TOTALL Diabetes Hormone Institute (IN), Fortis Hospital (IN), Diabetes Thyroid Hormone Research Institute (IN), Osmania Medical College (IN)